Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
concentration-dependent | effect varies with the concentration achieved | The pharmacology review describes concentration-dependent activity. | Assessment | Drug levels - exposure and pharmacokinetics |
time-dependent | effect relates to the duration above a relevant threshold in this context | The consultant describes time-dependent antimicrobial activity. | Assessment | Drug levels - exposure and pharmacokinetics |
systemic exposure | extent of drug reaching the systemic circulation over time | The assessment considers total systemic exposure over the dosing interval. | Assessment | Drug levels - exposure and pharmacokinetics |
area under the curve | drug exposure integrated over a stated time interval | The estimated area under the curve was reported for a 24-hour period. | Assessment | Drug levels - exposure and pharmacokinetics |
| area under the concentration-time curve across 24 hours | The calculated AUC24 is recorded in mg*h/L. | Assessment | Drug levels - exposure and pharmacokinetics | |
AUC/MIC | drug exposure divided by the organism's minimum inhibitory concentration | The consult reports AUC/MIC and states the MIC and method used. | Assessment | Drug levels - exposure and pharmacokinetics |
| maximum concentration in the specified concentration-time profile | The model's Cmax is listed separately from the single timed sample. | Assessment | Drug levels - exposure and pharmacokinetics | |
| minimum concentration in the specified concentration-time profile | The modeled Cmin corresponds to the end of the stated interval. | Assessment | Drug levels - exposure and pharmacokinetics | |
| time at which the maximum concentration occurs | The report gives an estimated Tmax for the oral formulation. | Assessment | Drug levels - exposure and pharmacokinetics | |
half-life | time for concentration to fall by half during a specified elimination phase | The estimated half-life reflects the sampling period used in the model. | Assessment | Drug levels - exposure and pharmacokinetics |
elimination | removal of drug by metabolism and excretion | The falling concentrations are being reviewed alongside renal elimination. | Assessment | Drug levels - exposure and pharmacokinetics |
distribution phase | period during which drug moves between body compartments | The early specimen may reflect the distribution phase. | Assessment | Drug levels - exposure and pharmacokinetics |
postdistributional | obtained after the initial distribution phase | Sampling time was reviewed before labeling the level postdistributional. | Assessment | Drug levels - exposure and pharmacokinetics |
volume of distribution | apparent volume relating amount in the body to measured concentration | The model's volume of distribution is reported with its units. | Assessment | Drug levels - exposure and pharmacokinetics |
linear kinetics | concentration or exposure changes proportionally with dose under stated conditions | The dosing model assumes linear kinetics over the range examined. | Assessment | Drug levels - exposure and pharmacokinetics |
nonlinear kinetics | exposure changes out of proportion to the change in dose | The clinical pharmacist considered nonlinear kinetics when reviewing the concentration trend. | Assessment | Drug levels - exposure and pharmacokinetics |
saturable metabolism | metabolic capacity becomes limiting as concentration rises | The assessment notes possible saturable metabolism when interpreting the phenytoin trend. | Assessment | Drug levels - exposure and pharmacokinetics |
first-order elimination | constant fraction removed per unit time under the model | The pharmacokinetic estimate assumes first-order elimination. | Assessment | Drug levels - exposure and pharmacokinetics |
zero-order elimination | constant amount removed per unit time over the stated range | The toxicology note discusses zero-order elimination at the observed exposure. | Assessment | Drug levels - exposure and pharmacokinetics |
clearance estimate | calculated ability to eliminate drug per unit time | The clearance estimate depends on the sampling times entered. | Assessment | Drug levels - exposure and pharmacokinetics |
renal clearance | removal of a drug or analyte by the kidneys | The assessment considers reduced renal clearance after the creatinine increase. | Assessment | Drug levels - exposure and pharmacokinetics |
hepatic clearance | removal of a drug by the liver | The review considers changes in hepatic clearance since the prior measurement. | Assessment | Drug levels - exposure and pharmacokinetics |
extracorporeal clearance | removal by an external treatment circuit | The monitoring note accounts for extracorporeal clearance during dialysis. | Assessment | Drug levels - exposure and pharmacokinetics |
dialyzability | extent to which a substance can be removed by dialysis | The review considers the drug's dialyzability and the treatment modality. | Assessment | Drug levels - exposure and pharmacokinetics |
rebound concentration | increase after an initial decline owing to redistribution or another cause | The team compared the rebound concentration with the end-of-session measurement. | Assessment | Drug levels - exposure and pharmacokinetics |